The Cancer Letter

Inside information on cancer research and drug development

Vol.
30
No.
28
July 09, 2004Jul 09, 2004
Free
DOWNLOAD THE PDF

FDA seeks support for reorganization of cancer programs, but debate continues.

In a letter, ASCO reaffirms its views on oncology consolidation at FDA.

Also in this 8-page issue: NCI advisors approve $15-million set-aside for laboratory testing on “reduced harm” tobacco products.

Board approves continuation of partnerships between minority institutions and cancer centers for research, training, and outreach.

Duke recruits Judd Moul as chief of urology.

Foundation offers funds for mesothelioma research.

Other NCI funding opportunities listed.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account